Brazilian informatics solution
A Brazilian pharmaceutical supply group has implemented an integrated informatics solution from Thermo Fisher Scieintifc, consisting of a laboratory information management system and a chromatography data system.
A Brazilian pharmaceutical supply group has implemented an integrated informatics solution from Thermo Fisher Scieintifc, consisting of a laboratory information management system and a chromatography data system. It is reported that the company, GPSG Brazil, will use the system to enhance quality control in its São José dos Campos pharmaceutical production facility in São Paulo, Brazil.
Discussing the choice of system, Ronaldo Galvao, quality operations director said, “We needed a validated product that provides us with sufficient flexibility to deliver all the requirements of a pharmaceutical plant. The overall integration of our connected informatics solutions provides a seamless and secure quality environment.”
Every month, the Brazilian manufacturing plant processes more than 10,000 analyses to ensure the quality of nearly 2000 samples of raw materials, packaging materials, semi-finished and finished products, in addition to water and stability testing.
“Thermo Fisher Scientific works with many of the world’s leading pharmaceutical companies to support their manufacturing quality and ensure their ongoing success,” added Dave Champagne, vice president and general manager, Informatics at Thermo Fisher Scientific. “Our growing presence in South America providing informatics solutions to a broad range of industries is strengthened by our work with GPSG Brazil to support their ongoing production schedules and to improve their processes.”
For further information visit www.thermoscientific.com/janssen-cilag
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
